Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Logothetis

Showing results (51-60 of 150) with videos related to

Pageof 15
Sort By:
The Journal of Urology|December 1, 1986
Orchiectomy in advanced germ cell cancer following intensive chemotherapy: a comparison of systemic to testicular responseC Chong, C J Logothetis, A von Eschenbach, et al.
Cancer Metastasis Reviews|August 24, 1999
Model systems of prostate cancer: uses and limitationsN M Navone, C J Logothetis, A C von Eschenbach, et al.
The Journal of Urology|July 1, 1988
Genetic abnormalities in men with germ cell tumorsF H Dexeus, C J Logothetis, C Chong, et al.
Journal of Korean Medical Science|September 15, 1999
Management consideration in nonpulmonary visceral metastatic seminoma of testisD S Park, D M Prow, R J Amato, et al.
The Journal of Urology|November 1, 1995
Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignanciesS M Tu, E Hossan, R Amato, et al.
Anticancer Research|May 5, 1999
Schedule-dependence of C-CAM1 adenovirus gene therapy in a prostate cancer modelS H Lin, Y S Pu, W Luo, et al.
Journal of the National Cancer Institute|February 20, 1991
Fluorouracil and recombinant human interferon alfa-2a in the treatment of metastatic chemotherapy-refractory urothelial tumorsC J Logothetis, E Hossan, A Sella, et al.
Oncogene|January 8, 1999
Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53J L Herrmann, F Briones, S Brisbay, et al.
Urology|March 1, 1989
Radiation therapy-associated invasive bladder tumorsA Sella, F H Dexeus, C Chong, et al.
Anticancer Research|July 1, 1995
Antiproliferative effects of cyclocreatine on human prostatic carcinoma cellsN M Hoosein, K J Martin, M Abdul, et al.
Pageof 15

Showing results (51-60 of 150) with videos related to

Sort By:
Pageof 15
The Journal of Urology|December 1, 1986
Orchiectomy in advanced germ cell cancer following intensive chemotherapy: a comparison of systemic to testicular responseC Chong, C J Logothetis, A von Eschenbach, et al.
Cancer Metastasis Reviews|August 24, 1999
Model systems of prostate cancer: uses and limitationsN M Navone, C J Logothetis, A C von Eschenbach, et al.
The Journal of Urology|July 1, 1988
Genetic abnormalities in men with germ cell tumorsF H Dexeus, C J Logothetis, C Chong, et al.
Journal of Korean Medical Science|September 15, 1999
Management consideration in nonpulmonary visceral metastatic seminoma of testisD S Park, D M Prow, R J Amato, et al.
The Journal of Urology|November 1, 1995
Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignanciesS M Tu, E Hossan, R Amato, et al.
Anticancer Research|May 5, 1999
Schedule-dependence of C-CAM1 adenovirus gene therapy in a prostate cancer modelS H Lin, Y S Pu, W Luo, et al.
Journal of the National Cancer Institute|February 20, 1991
Fluorouracil and recombinant human interferon alfa-2a in the treatment of metastatic chemotherapy-refractory urothelial tumorsC J Logothetis, E Hossan, A Sella, et al.
Oncogene|January 8, 1999
Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53J L Herrmann, F Briones, S Brisbay, et al.
Urology|March 1, 1989
Radiation therapy-associated invasive bladder tumorsA Sella, F H Dexeus, C Chong, et al.
Anticancer Research|July 1, 1995
Antiproliferative effects of cyclocreatine on human prostatic carcinoma cellsN M Hoosein, K J Martin, M Abdul, et al.
Pageof 15